Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
170M
-
Number of holders
-
145
-
Total 13F shares, excl. options
-
55.5M
-
Shares change
-
-2.94M
-
Total reported value, excl. options
-
$1.05B
-
Value change
-
-$33.1M
-
Put/Call ratio
-
0.74
-
Number of buys
-
83
-
Number of sells
-
-69
-
Price
-
$18.97
Significant Holders of Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) as of Q2 2023
183 filings reported holding IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share as of Q2 2023.
Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) has 145 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55.5M shares
of 170M outstanding shares and own 32.65% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5.47M shares), Deep Track Capital, LP (5.42M shares), FMR LLC (5.25M shares), BlackRock Inc. (4.2M shares), STATE STREET CORP (3.23M shares), PERCEPTIVE ADVISORS LLC (2.52M shares), Logos Global Management LP (2.25M shares), Avidity Partners Management LP (2.09M shares), Redmile Group, LLC (1.92M shares), and Alpine Global Management, LLC (1.44M shares).
This table shows the top 145 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.